Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating

NCT ID: NCT01642914

Last Updated: 2016-04-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

487 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the efficacy and safety of linaclotide compared with placebo in patients with chronic constipation (CC) and prominent abdominal bloating. This study includes an up to 3-week screening period and a 2-3 week pretreatment period. Patients who are eligible will be randomized to one of two doses of linaclotide or placebo for 12 weeks. This 12-week study will assess the effects of linaclotide on bowel movement frequency, as well as other abdominal and bowel symptoms of CC.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Constipation Constipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Linaclotide 290 micrograms

Linaclotide 290 micrograms

Group Type EXPERIMENTAL

Linaclotide 290 micrograms

Intervention Type DRUG

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Linaclotide 145 Micrograms

Linaclotide 145 micrograms

Group Type EXPERIMENTAL

Linaclotide 145 micrograms

Intervention Type DRUG

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Placebo

Matching placebo

Group Type PLACEBO_COMPARATOR

Matching placebo

Intervention Type DRUG

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Linaclotide 290 micrograms

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Intervention Type DRUG

Linaclotide 145 micrograms

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Intervention Type DRUG

Matching placebo

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has completed a colonoscopy according to the American Gastroenterological Association criteria with no clinically significant findings
* Patient has successfully completed protocol procedures (with no clinically significant findings)
* Patient meets protocol criteria for Chronic Constipation(CC): \< 3 bowel movements per week and reports one or more of the following symptoms for at least 12 weeks:

1. Straining during more than 25% of BMs
2. Lumpy or hard stools during more than 25% of BMs
3. Sensation of incomplete evacuation during more than 25% of BMs
* Patient demonstrates continued chronic constipation and bloating through Pretreatment Period
* Patient is compliant with Interactive voice response System (IVRS)

Exclusion Criteria

* Patient has a history of loose or watery stools
* Patient has symptoms of or been diagnosed with Irritable Bowel Syndrome (IBS)
* Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility
* Patient has any protocol-excluded or clinically significant medical or surgical history that would limit the patient's ability to complete or participate in this clinical trial or could confound the study assessments
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ironwood Pharmaceuticals, Inc.

INDUSTRY

Sponsor Role collaborator

Forest Laboratories

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steven Shiff, MD

Role: STUDY_DIRECTOR

Forest Laboratories

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Forest Investigative Site 020

Chandler, Arizona, United States

Site Status

Forest Investigative Site 102

Chandler, Arizona, United States

Site Status

Forest Investigative Site 149

Glendale, Arizona, United States

Site Status

Forest Investigative Site 126

Goodyear, Arizona, United States

Site Status

Forest Investigative Site 018

Phoenix, Arizona, United States

Site Status

Forest Investigative Site 061

Phoenix, Arizona, United States

Site Status

Forest Investigative Site 022

Scottsdale, Arizona, United States

Site Status

Forest Investigative Site 079

Tucson, Arizona, United States

Site Status

Forest Investigative Site 071

Tucson, Arizona, United States

Site Status

Forest Investigative Site 135

North Little Rock, Arkansas, United States

Site Status

Forest Investigative Site 106

Anaheim, California, United States

Site Status

Forest Investigative Site 104

Laguna Hills, California, United States

Site Status

Forest Investigative Site 066

Mission Hills, California, United States

Site Status

Forest Investigative Site 095

San Carlos, California, United States

Site Status

Forest Investigative Site 009

San Diego, California, United States

Site Status

Forest Investigative Site 151

Santa Monica, California, United States

Site Status

Forest Investigative Site 010

Westlake Village, California, United States

Site Status

Forest Investigative Site 012

Boulder, Colorado, United States

Site Status

Forest Investigative Site 041

Colorado Springs, Colorado, United States

Site Status

Forest Investigative Site 045

Colorado Springs, Colorado, United States

Site Status

Forest Investigative Site 060

Longmont, Colorado, United States

Site Status

Forest Investigative Site 007

Bristol, Connecticut, United States

Site Status

Forest Investigative Site 153

Waterbury, Connecticut, United States

Site Status

Forest Investigative Site 091

Boynton Beach, Florida, United States

Site Status

Forest Investigative Site 047

Bradenton, Florida, United States

Site Status

Forest Investigative Site 042

Brooksville, Florida, United States

Site Status

Forest Investigative Site 133

Coral Gables, Florida, United States

Site Status

Forest Investigative Site 131

DeLand, Florida, United States

Site Status

Forest Investigative Site 051

Fort Myers, Florida, United States

Site Status

Forest Investigative Site 137

Inverness, Florida, United States

Site Status

Forest Investigative Site 114

Jacksonville, Florida, United States

Site Status

Forest Investigative Site 004

Jupiter, Florida, United States

Site Status

Forest Investigative Site 016

Kissimmee, Florida, United States

Site Status

Forest Investigative Site 097

Lauderdale Lakes, Florida, United States

Site Status

Forest Investigative Site 003

Miami, Florida, United States

Site Status

Forest Investigative Site 002

Miami, Florida, United States

Site Status

Forest Investigative Site 130

New Smyrna Beach, Florida, United States

Site Status

Forest Investigative Site 040

Ocala, Florida, United States

Site Status

Forest Investigative Site 083

Orlando, Florida, United States

Site Status

Forest Investigative Site 150

Oviedo, Florida, United States

Site Status

Forest Investigative Site 132

Port Orange, Florida, United States

Site Status

Forest Investigative Site 127

Seminole, Florida, United States

Site Status

Forest Investigative Site 087

St. Petersburg, Florida, United States

Site Status

Forest Investigative Site 064

Tampa, Florida, United States

Site Status

Forest Investigative Site 115

Zephyrhills, Florida, United States

Site Status

Forest Investigative Site 021

Marietta, Georgia, United States

Site Status

Forest Investigative Site 011

Marietta, Georgia, United States

Site Status

Forest Investigative Site 109

Sandy Springs, Georgia, United States

Site Status

Forest Investigative Site 037

Stockbridge, Georgia, United States

Site Status

Forest Investigative Site 023

Woodstock, Georgia, United States

Site Status

Forest Investigative Site 015

Idaho Falls, Idaho, United States

Site Status

Forest Investigative Site 122

Peoria, Illinois, United States

Site Status

Forest Investigative Site 043

Rockford, Illinois, United States

Site Status

Forest Investigative Site 107

Anderson, Indiana, United States

Site Status

Forest Investigative Site 117

Clive, Iowa, United States

Site Status

Forest Investigative Site 146

Clive, Iowa, United States

Site Status

Forest Investigative Site 143

Davenport, Iowa, United States

Site Status

Forest Investigative Site 055

Iowa City, Iowa, United States

Site Status

Forest Investigative Site 028

Newton, Kansas, United States

Site Status

Forest Investigative Site 112

Overland Park, Kansas, United States

Site Status

Forest Investigative Site 034

Wichita, Kansas, United States

Site Status

Forest Investigative Site 032

Wichita, Kansas, United States

Site Status

Forest Investigative Site 128

Lexington, Kentucky, United States

Site Status

Forest Investigative Site 134

Madisonville, Kentucky, United States

Site Status

Forest Investigative Site 121

Baton Rouge, Louisiana, United States

Site Status

Forest Investigative Site 124

Metairie, Louisiana, United States

Site Status

Forest Investigative Site 101

Monroe, Louisiana, United States

Site Status

Forest Investigative Site 058

Shreveport, Louisiana, United States

Site Status

Forest Investigative Site 099

Shreveport, Louisiana, United States

Site Status

Forest Investigative Site 062

Baltimore, Maryland, United States

Site Status

Forest Investigative Site 008

Chevy Chase, Maryland, United States

Site Status

Forest Investigative Site 014

Hagerstown, Maryland, United States

Site Status

Forest Investigative Site 024

Towson, Maryland, United States

Site Status

Forest Investigative Site 006

Boston, Massachusetts, United States

Site Status

Forest Investigative Site 070

Chesterfield, Michigan, United States

Site Status

Forest Investigative Site 145

Traverse City, Michigan, United States

Site Status

Forest Investigative Site 141

Jackson, Mississippi, United States

Site Status

Forest Investigative Site 077

Fremont, Nebraska, United States

Site Status

Forest Investigative Site 048

Omaha, Nebraska, United States

Site Status

Forest Investigative Site 052

Henderson, Nevada, United States

Site Status

Forest Investigative Site 080

Las Vegas, Nevada, United States

Site Status

Forest Investigative Site 036

Clifton, New Jersey, United States

Site Status

Forest Investigative Site 088

Marlton, New Jersey, United States

Site Status

Forest Investigative Site 033

Vineland, New Jersey, United States

Site Status

Forest Investigative Site 063

Albuquerque, New Mexico, United States

Site Status

Forest Investigative Site 093

Albuquerque, New Mexico, United States

Site Status

Forest Investigative Site 044

Brooklyn, New York, United States

Site Status

Forest Investigative Site 017

Great Neck, New York, United States

Site Status

Forest Investigative Site 142

Asheboro, North Carolina, United States

Site Status

Forest Investigative Site 094

Asheville, North Carolina, United States

Site Status

Forest Investigative Site 075

Boone, North Carolina, United States

Site Status

Forest Investigative Site 123

Chapel Hill, North Carolina, United States

Site Status

Forest Investigative Site 140

Davidson, North Carolina, United States

Site Status

Forest Investigative Site 039

Fayetteville, North Carolina, United States

Site Status

Forest Investigative Site 031

Greensboro, North Carolina, United States

Site Status

Forest Investigative Site 029

Greensboro, North Carolina, United States

Site Status

Forest Investigative Site 078

Greensboro, North Carolina, United States

Site Status

Forest Investigative Site 084

Harrisburg, North Carolina, United States

Site Status

Forest Investigative Site 073

Hickory, North Carolina, United States

Site Status

Forest Investigative Site 050

Hickory, North Carolina, United States

Site Status

Forest Investigative Site 139

High Point, North Carolina, United States

Site Status

Forest Investigative Site 027

Raleigh, North Carolina, United States

Site Status

Forest Investigative Site 119

Statesville, North Carolina, United States

Site Status

Forest Investigative Site 089

Wilmington, North Carolina, United States

Site Status

Forest Investigative Site 074

Winston-Salem, North Carolina, United States

Site Status

Forest Investigative Site 025

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 120

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 056

Cleveland, Ohio, United States

Site Status

Forest Investigative Site 026

Columbus, Ohio, United States

Site Status

Forest Investigative Site 098

Dayton, Ohio, United States

Site Status

Forest Investigative Site 090

Dayton, Ohio, United States

Site Status

Forest Investigative Site 085

Mentor, Ohio, United States

Site Status

Forest Investigative Site 068

Wadsworth, Ohio, United States

Site Status

Forest Investigative Site 118

Oklahoma City, Oklahoma, United States

Site Status

Forest Investigative Site 081

Levittown, Pennsylvania, United States

Site Status

Forest Investigative Site 001

Pittsburgh, Pennsylvania, United States

Site Status

Forest Investigative Site 110

Reading, Pennsylvania, United States

Site Status

Forest Investigative Site 116

Greer, South Carolina, United States

Site Status

Forest Investigative Site 046

Simpsonville, South Carolina, United States

Site Status

Forest Investigative Site 092

Dakota Dunes, South Dakota, United States

Site Status

Forest Investigative Site 129

Chattanooga, Tennessee, United States

Site Status

Forest Investigative Site 138

Kingsport, Tennessee, United States

Site Status

Forest Investigative Site 125

Austin, Texas, United States

Site Status

Forest Investigative Site 035

Dallas, Texas, United States

Site Status

Forest Investigative Site 005

Dallas, Texas, United States

Site Status

Forest Investigative Site 111

Fort Worth, Texas, United States

Site Status

Forest Investigative Site 100

Houston, Texas, United States

Site Status

Forest Investigative Site 067

Katy, Texas, United States

Site Status

Forest Investigative Site 049

Pasadena, Texas, United States

Site Status

Forest Investigative Site 030

San Antonio, Texas, United States

Site Status

Forest Investigative Site 076

San Antonio, Texas, United States

Site Status

Forest Investigative Site 065

Sugarland, Texas, United States

Site Status

Forest Investigative Site 019

Ogden, Utah, United States

Site Status

Forest Investigative Site 105

Salt Lake City, Utah, United States

Site Status

Forest Investigative Site 113

Sandy City, Utah, United States

Site Status

Forest Investigative Site 053

Charlottesville, Virginia, United States

Site Status

Forest Investigative Site 108

Chesapeake, Virginia, United States

Site Status

Forest Investigative Site 136

Chesapeake, Virginia, United States

Site Status

Forest Investigative Site 148

Christiansburg, Virginia, United States

Site Status

Forest Investigative Site 072

Lynchburg, Virginia, United States

Site Status

Forest Investigative Site 069

Newport News, Virginia, United States

Site Status

Forest Investigative Site 013

Norfolk, Virginia, United States

Site Status

Forest Investigative Site 038

Richmond, Virginia, United States

Site Status

Forest Investigative Site 103

Spokane, Washington, United States

Site Status

Forest Investigative Site 082

La Crosse, Wisconsin, United States

Site Status

Forest Investigative Site 096

Milwaukee, Wisconsin, United States

Site Status

Forest Investigative Site 054

Greater Sudbury, Ontario, Canada

Site Status

Forest Investigative Site 059

Sarnia, Ontario, Canada

Site Status

Forest Investigative Site 086

Toronto, Ontario, Canada

Site Status

Forest Investigative Site 147

Toronto, Ontario, Canada

Site Status

Forest Investigative Site 152

Vaughan, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

References

Explore related publications, articles, or registry entries linked to this study.

Lacy BE, Shea EP, Manuel M, Abel JL, Jiang H, Taylor DCA. Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. PLoS One. 2021 Jan 11;16(1):e0243318. doi: 10.1371/journal.pone.0243318. eCollection 2021.

Reference Type DERIVED
PMID: 33428631 (View on PubMed)

Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS One. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349. eCollection 2015.

Reference Type DERIVED
PMID: 26222318 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LIN-MD-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect to Linaclotide on Colonic Motility
NCT06989268 COMPLETED PHASE4
Linaclotide for Colonoscopy Bowel Prep
NCT06692673 NOT_YET_RECRUITING PHASE1/PHASE2